HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G's China E-Commerce Sales Point In Direction Of Future Growth

This article was originally published in The Rose Sheet

Executive Summary

P&G China's e-commerce business is growing at 60%, with seven of 10 categories holding or growing online market share, the firm’s Chinese e-commerce head says. Its global personal health care segment struggled in its latest quarter due to lower levels of product innovation compared to year-ago period.

You may also be interested in...



P&G Counts Board Vote Win As Peltz Claims 'Change' Message Delivered

Procter & Gamble says preliminary results keep billionaire activist investor Nelson Peltz off its board and re-elect its 11 incumbents. However, Peltz plans to challenge the vote outcome and analysts agree that his pressure for change at P&G scored points with shareholders.

Legacy Consumer Health Firms Invest To Compete In Start-Ups' Realm: E-Commerce

J&J, Colgate, P&G and Church & Dwight look to e-commerce to regain market share from smaller, nimble consumer health brands and digital-based retail start-ups, executives say at Barclays Global Consumer Staples conference.

J&J Consumer Health Brands Deliver Local Connections In Startup Style

J&J is growing Listerine mouthwash sales tapping into local tastes while continuing a global marketing push, says consumer business chief Jorge Mesquita. The firm also is developing strategy to make its brands “ambidextrous,” competing among small as well as large businesses.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121272

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel